Hirano T, Franzén B, Kato H, Ebihara Y, Auer G
Department of Tumor Pathology, Karolinska Institute, Stockholm, Sweden.
Am J Pathol. 1994 Feb;144(2):296-302.
Squamous cell lung carcinomas (SCCs) represent a highly malignant group of tumors, and effective treatment is greatly dependent upon early diagnosis. However, objective diagnosis of atypia is difficult and useful markers need to be defined. In this study, genomic instability, cell proliferation, and cellular accumulation of mutant p53, as reflected by DNA aneuploidy, proliferating cell nuclear antigen, and p53 immunoreactivity, respectively, were evaluated in bronchial squamous metaplasia without atypia (n = 4), bronchial squamous metaplasia with low-grade atypia (n = 12), bronchial squamous metaplasia with high-grade atypia (n = 15), early-stage SCC (n = 15), and advanced-stage SCC (n = 33). Our results suggest that hyperproliferation is an early event followed by DNA aneuploidy, which in turn precedes p53 immunoreactivity in the genesis of SCC. We conclude that routine assessment of proliferating cell nuclear antigen, DNA ploidy, and p53 may be valuable for the early diagnosis of SCC.
肺鳞状细胞癌(SCCs)是一类高度恶性的肿瘤,有效的治疗很大程度上依赖于早期诊断。然而,非典型性的客观诊断困难,需要确定有用的标志物。在本研究中,分别通过DNA非整倍体、增殖细胞核抗原和p53免疫反应性反映的基因组不稳定性、细胞增殖以及突变型p53的细胞蓄积,在无非典型性的支气管鳞状化生(n = 4)、低级别非典型性支气管鳞状化生(n = 12)、高级别非典型性支气管鳞状化生(n = 15)、早期SCC(n = 15)和晚期SCC(n = 33)中进行了评估。我们的结果表明,增殖过度是DNA非整倍体之前的早期事件,而DNA非整倍体又先于SCC发生过程中的p53免疫反应性。我们得出结论,对增殖细胞核抗原、DNA倍体和p53进行常规评估可能对SCC的早期诊断有价值。